CAVYX
Price
$18.58
Change
+$0.08 (+0.43%)
Updated
Jun 2 closing price
Net Assets
451.11M
RWMFX
Price
$68.79
Change
+$0.27 (+0.39%)
Updated
Jun 2 closing price
Net Assets
214.46B
Interact to see
Advertisement

CAVYX vs RWMFX

Header iconCAVYX vs RWMFX Comparison
Open Charts CAVYX vs RWMFXBanner chart's image
CAVYX vs RWMFX Comparison Chart in %
View a ticker or compare two or three
VS
CAVYX vs. RWMFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAVYX is a Buy and RWMFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMFX has more cash in the bank: 214B vs. CAVYX (451M). RWMFX pays higher dividends than CAVYX: RWMFX (1.40) vs CAVYX (0.78). CAVYX was incepted earlier than RWMFX: CAVYX (11 years) vs RWMFX (24 years). CAVYX (0.98) is less costly to investors than RWMFX (0.31). RWMFX is a more actively managed with annual turnover of: 29.00 vs. CAVYX (21.00). RWMFX has a lower initial minimum investment than CAVYX: RWMFX (250) vs CAVYX (500). CAVYX annual gain was more profitable for investors over the last year : 15.85 vs. RWMFX (7.92). RWMFX return over 5 years is better than : 26.49 vs. CAVYX (15.70).
CAVYXRWMFXCAVYX / RWMFX
Total Expense Ratio0.760.31245%
Annual Report Gross Expense Ratio0.980.31316%
Fund Existence11 years24 years-
Gain YTD9.4035.991157%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets451M214B0%
Annual Yield % from dividends0.781.4056%
Returns for 1 year15.857.92200%
Returns for 3 years46.0133.64137%
Returns for 5 years15.7026.4959%
Returns for 10 years114.5486.15133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RF28.030.69
+2.52%
Regions Financial Corp
JMG6.61N/A
N/A
JM Group Ltd.
GDOT12.68-0.09
-0.70%
Green Dot Corp
DTST3.57-0.18
-4.68%
Data Storage Corp
CRNX32.59-1.93
-5.59%
Crinetics Pharmaceuticals